CX Institutional’s AdaptHealth AHCO Stock Holding History

CX Institutional’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,028	Closed	-$263K	–	502
2022 Q3	$263K	Buy	14,028 +3,598	+34%	+$74K	0.02%	404
2022 Q2	$188K	Buy	+10,430	New	+$169K	0.01%	446

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CX Institutional's AHCO Position: Q4 2022 in Review

CX Institutional sold out of AdaptHealth (AHCO) in Q4 2022, closing a stake of 14,028 shares — an estimated $263K sold.

CX Institutional first reported a position in AHCO in Q2 2022 and held it in 2 quarters. The position peaked at $263K in Q3 2022. 193 funds tracked by Wall St. Rank hold AHCO as of Q4 2022.

CX Institutional reported no remaining AdaptHealth position as of Q4 2022 after selling out during the quarter.
CX Institutional sold 14,028 AdaptHealth shares in Q4 2022, an estimated $263K.
CX Institutional first reported a position in AdaptHealth in Q2 2022 and held it in 2 quarters.
CX Institutional's AdaptHealth position peaked at $263K in Q3 2022.
193 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2022.

Based on CX Institutional's 13F filing for Q4 2022, filed 3 Feb 2023.